Your browser doesn't support javascript.
loading
Estimating sleep stages using cardiorespiratory signals: validation of a novel algorithm across a wide range of sleep-disordered breathing severity.
Bakker, Jessie P; Ross, Marco; Vasko, Ray; Cerny, Andreas; Fonseca, Pedro; Jasko, Jeff; Shaw, Edmund; White, David P; Anderer, Peter.
Afiliação
  • Bakker JP; Philips Sleep and Respiratory Care, Monroeville, Pennsylvania.
  • Ross M; Philips Sleep and Respiratory Care, Vienna, Austria.
  • Vasko R; Philips Sleep and Respiratory Care, Monroeville, Pennsylvania.
  • Cerny A; Philips Sleep and Respiratory Care, Vienna, Austria.
  • Fonseca P; Philips Research, Eindhoven, the Netherlands.
  • Jasko J; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • Shaw E; Philips Sleep and Respiratory Care, Monroeville, Pennsylvania.
  • White DP; Philips Sleep and Respiratory Care, Monroeville, Pennsylvania.
  • Anderer P; Philips Sleep and Respiratory Care, Monroeville, Pennsylvania.
J Clin Sleep Med ; 17(7): 1343-1354, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33660612
STUDY OBJECTIVES: We have developed the CardioRespiratory Sleep Staging (CReSS) algorithm for estimating sleep stages using heart rate variability and respiration, allowing for estimation of sleep staging during home sleep apnea tests. Our objective was to undertake an epoch-by-epoch validation of algorithm performance against the gold standard of manual polysomnography sleep staging. METHODS: Using 296 polysomnographs, we created a limited montage of airflow and heart rate and deployed CReSS to identify each 30-second epoch as wake, light sleep (N1 + N2), deep sleep (N3), or rapid eye movement (REM) sleep. We calculated Cohen's kappa and the percentage of accurately identified epochs. We repeated our analyses after stratification by sleep-disordered breathing (SDB) severity, and after adding thoracic respiratory effort as a backup signal for periods of invalid airflow. RESULTS: CReSS discriminated wake/light sleep/deep sleep/REM sleep with 78% accuracy; the kappa value was 0.643 (95% confidence interval, 0.641-0.645). Discrimination of wake/sleep demonstrated a kappa value of 0.711 and accuracy of 89%, non-REM sleep/REM sleep demonstrated a kappa of 0.790 and accuracy of 94%, and light sleep/deep sleep demonstrated a kappa of 0.469 and accuracy of 87%. Kappa values did not vary by more than 0.07 across subgroups of no SDB, mild SDB, moderate SDB, and severe SDB. Accuracy increased to 80%, with a kappa value of 0.680 (95% confidence interval, 0.678-0.682), when CReSS additionally utilized the thoracic respiratory effort signal. CONCLUSIONS: We observed substantial agreement between CReSS and the gold-standard comparator of manual sleep staging of polysomnographic signals, which was consistent across the full range of SDB severity. Future research should focus on the extent to which CReSS reduces the discrepancy between the apnea-hypopnea index and the respiratory event index, and the ability of CReSS to identify REM sleep-related obstructive sleep apnea.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes da Apneia do Sono / Fases do Sono Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes da Apneia do Sono / Fases do Sono Idioma: En Ano de publicação: 2021 Tipo de documento: Article